Clinical Trial Update: A Study To Assess the Safety of Extended Release Alprazolam for the Treatment of Adolescents With Panic Disorder or Anxiety With Panic Attacks [Phase 4]

View source ↗

Summary

Phase 4 trial assessing safety of extended release alprazolam in adolescents with panic disorder; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Panic Disorder

Drugs mentioned

• Extended release alprazolam (alprazolam extended-release)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Panic Disorder | Phase 4 | Status: TERMINATED